RecruitingNCT06778746
Use of Biologics for Severe Asthma in Hong Kong
Sponsor
Chinese University of Hong Kong
Enrollment
360 participants
Start Date
Dec 26, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The landscape of biologics therapy used in Hong Kong is currently unknown. The purpose of this study is to conduct a retrospective analysis of the use of biologics treatment for severe asthma in Hong Kong. The study aims to assess the landscape of biologics usage, evaluate the characteristics and conditions of patients before and after receiving biologic therapy, and provide insights into the effectiveness and safety of these treatments in the local population.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patients aged 18 years or older.
- Patients diagnosed with severe asthma per the Global Initiative for Asthma (GINA) guidelines.
- Patients who have received biologic therapy for treatment of asthma (including those who received just one dose to allow assessment of the reason for withdrawal)
Exclusion Criteria1
- \- Patients with respiratory diseases with other known significant respiratory diseases, including tuberculosis (TB)-destroyed lung parenchyma, history of lung resection and lung cancer
Interventions
OTHERno interventions
No interventions, this is an observational study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06778746
Related Trials
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267393 locations
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
NCT06664619138 locations
Genetic Association With Various Severities, Phenotypes and Endotypes of Asthma.
NCT061960342 locations
Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma
NCT047069881 location
To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong
NCT046397911 location